AzTrials
AzTrials

the Efficacy and Performance of the Pediatric I-gel MaskNCT03748589

Application of I-gel Laryngeal Mask Airway in Pediatric Patients

A study testing laryngeal mask airway in people with the Efficacy and Performance of the Pediatric I-gel Mask, run by Xian Children's Hospital at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background The laryngeal mask airway (LMA) is a supraglottic airway device ,which is commonly used to manage children's airways, because it is typically easy to use and can avoid problems specific to tracheal intubation. Read more about this study

Who is it for?
Ages 1 day to 108 months
What is being tested?
laryngeal mask airway
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
413 participants
Where
1 siteChina
Study dates
12 Dec 2018to 30 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 108 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Weight between 2 to 35 kg ASA physical status Ι or Ⅱ elective surgery operation time not longer than four hours general anesthesia

Who cannot join

  • a history of upper respiratory tract infection two weeks before operation risk of aspiration (such as non-fasting status , gastroesophageal reflux disease and hiatus hernia) lung diseases limited head-neck movements those refusing to participate children whose EEG showing bradycardia and conduction block

Trial locations and contacts

1 site in 1 country.

China1 site
  • Xi'an Children's Hospital

    Xi'an, Shaanxi, 710000

Other trials in China

About this study

Official title: Application of I-gel Laryngeal Mask Airway in Infants and Children Undergoing Surgical Procedures

Background The laryngeal mask airway (LMA) is a supraglottic airway device ,which is commonly used to manage children's airways, because it is typically easy to use and can avoid problems specific to tracheal intubation. Since the LMA was introduced into clinical practice in 1988 , various types of LMAs have been developed, the safety and efficacy of which have been established in both adults and children.The paediatric i-gel is a relatively new and disposable supraglottic airway device for children, which is made of a soft gel-like elastomer with a non-inflatable cuff and a channel for gastric catheter placement . It does not require cuff inflation ,reducing the complications associated with compression trauma and high cuff pressure . Medical-grade thermoplastic elastomer creates a more intimate interface for interacting with supraglottic tissue. The usage of i-gel mask is more common in adults ,though a large scale study focusing on children is lacking.

Objectives:

Read more

To evaluate the efficacy and performance of the pediatric i-gel mask

Methods:

From November 2018 to March 2019, subjects are selected from patients who undergo elective surgery at Xi'an Children's Hospital, within the age of 0 to 108 months old, with an American Society of Anesthesiologists physical status I or II .They were assigned into four groups according to their weight. Four groups are : 2-5 kg (group 1#), 5.1-12.0 kg (group 1.5#), 10-25kg (group 2#) 25-35kg(group 2.5#). The primary outcome is the clinical performance of the airways: the rate of insertion at first attempt,the ease of insertion,the insertion time,the oropharyngeal leak pressure(OLP),the fibreoptic view and the ease of gastric tube insertion. The secondary outcome is the frequency of other perioperative complications as listed in the detail information section.

Read the detailed description

methods This is a prospective, randomized, parallel-group, single sample study ,which was approved by the Ethics Committee of Children's Hospital affiliated to Xi'an Jiaotong University.The experiment is expected to be completed between December 2018 and March 2019 in Xi'an children's Hospital, signed consent will be obtained from the parents or the guardian of the child participating in the study.The inclusion criteria are: children aged between 0 to 108 months, Weighed between 2 to 35 kg,with an American Standards Association (ASA )physical status Ι or Ⅱ, who are scheduled for elective surgery shorter than four hours under general anesthesia . In addition,the operation of supraglottic airway devices needs to be seamless during perioperative period. Children with below condition will be excluded form the experiment:a suspected difficult airway, a history of upper respiratory tract infection two weeks before operation ,being at risk of aspiration (such as non-fasting status , gastroesophageal reflux disease and hiatus hernia),lung diseases, limited head-neck movements, and those refusing to participate.The children with symptoms bradycardia and conduction block shown on EEG are also excluded from this experiment.The children were assigned into four groups based on their weights : size 1 for 2-5kg ,size 1.5 for 5-12 kg, size 2 for 10-25 kg, size 2.5 for 25-35 kg . The required device is prepared according to the child's weight and using the the manufacturer's guidelines . The children's group allocation were operated by a researcher who do not participate in post anesthesia care unit or outcome assessment. All children involved in the experiment, the children's parents, and the data analyzer are blind to the device used. In preparation for surgery,children are fasted 8h from solid food with fat content, 6h from semi-solid food and liquid food ,4h for breast milk and 2 h for clear water .Premedication is provided about 20 minutes before entering the operating room, by which children receive intranasal dexmedetomidine 1.5ug/kg, so that children can enter the operating room quietly. On arrival in the operating room, children were monitored using pulse oximetry, electrocardiography, non-invasive blood pressure, and capnography. General anaesthesia was induced with 100% oxygen 2-4 Liter(L)/min. Injection atropine 0.01mg/kg、fentanyl 2 μg/kg 、 propofol 2mg/kg 、vecuronium bromide 0.1 mg/kg intravenously (IV) in turn.After loss of consciousness, children are promptly positioned supine with an adequate sized roll underneath the neck to establish optimal position.Achieving appropriate anesthesia depth,children are randomised to have inserted i-gel ,The jaw thrust maneuver are used to confirm anesthesia depth whether it is suitable for placing the laryngeal mask and facilitating its placement. We do not administer neuromuscular blocking during intraoperative period. Two anesthesiologists came to the hospital for working at least one year and experienced in inserting supraglottic airway devices in at least 200 pediatric patients. The device was inserted according to the manufacturer's recommendations .Device insertion was considered successful by observing bilateral chest wall movement,as well as a stable square-wave capnogram trace ,the lung breath sound with no audible leak .Three failed insertion attempts are considered failed insertion of the device, and patients were withdrawn from the study.Tracheal intubation was considered after failure of three times of laryngeal mask airway placement.

Insertion time was measured from the moment a device was picked up until confirmation of the first wave on a capnogram,The ease of device placement was assessed using a subjective grading score of 1-4 (1: no resistance, 2: mild resistance, 3: moderate resistance, 4: inability to place the device) by the anesthesiologist. We also record the manipulations for improving device position, such as adjusting the insertion depth, conducting a jaw thrust maneuver, or flexion/extension of the head.

Oropharyngeal leak pressure and fiberoptic view through the device were assessed. Oropharyngeal leak pressure was determined by closing the adjustable pressure-limiting valve to 30 centimeter water column(cmH 2 O) at the fresh gas flow rate of 3 L/min, switching the mechanical ventilation to manual ventilation, and reading the airway pressure on the monitor in the anesthesia machine which an audible leak on auscultation over neck was defined as OLP. The OLP was not allowed to exceed 30 cmH 2 O to avoid barotrauma, If mean airway pressure is higher than OLP or insufficient ventilation (lesser than 5 ml/kg) occurred during the airway maintenance, proper manipulations (pushing or pulling of device, extension or flexion of the head, jaw thrust) were performed. If appropriate manipulation does not solve the problem, the device should be removed and endotracheal intubation be performed. The anatomical position of the LMA in relation to the glottis was evaluated by placing a fiberoptic bronchoscope through the device .The fiberoptic view is classified into four grades by observing the fiberoptic views (grade 1: vocal cords not visible, grade 2: vocal cords and anterior epiglottis visible, grade 3: vocal cords and posterior epiglottis visible, grade 4: only vocal cords visible). The 8-12 French size gastric tubes are used for those groups. A well-lubricated gastric tube is prepared before inserted into the stomach through gastric port of airway device. The assessment of correct placement is through detection of injected air by epigastric auscultation or by aspiration of gastric content .A grading scale(1:easy,2:difficult,3:failure) is used for assessing the ease of gastric tube insertion.Easy is defined as placing the tube successfully in the first attempt,difficult is defined as placing the tube successfully within two attempts, failure is defined as inability to establish correct placement within three placements.Anesthesia was maintained using 2%~3% sevoflurane and remifentanil 0.2~0.4ug/kg•min.1 ug/kg fentanyl is added again before the skin incision and suture. At the end of surgery, the anesthetics are terminated. The patient was then moved to the postanesthesia care unit (PACU).We recorded heart rate, mean blood pressure, oxygen saturation, peak inspiratory pressure and complications during the induction and maintenance of anesthesia. At the conclusion of the surgery, when the tidal volume is >6 ml/kg or end-tidal carbon dioxide(CO2) is less than 50 mmHg,we can stop the mechanical ventilation and keep the patient's spontaneous respiration. The LMA is removed when evidence of adequate emergence including spontaneous eye opening, grimacing using forehead and/or eyebrow, and purposeful movement. In addition,we also observed the complication such as coughing, bronchospasm, laryngospasm, desaturation (SpO 2 < 90%), regurgitation, aspiration, sore throat, blood-on LMA, postoperative nausea and vomiting (PONV), breath-holding and teeth or lip injury during anesthesia maintenance and emergence . A blinded investigator assessed all patients in the PACU and conducted a ward visit or telephone interview 24 h after the end of surgery. In our study, the primary outcome is oropharyngeal leak pressure,the secondary outcome are the rate of successful insertion at first attempt, fiberoptic view,insertion time,ease of insertion,ease of gastric tube insertion。 We recorded complications including coughing, breath-holding, desaturation, laryngospasm or bronchospasm,blood-on LMA, sore throat, postoperative nausea and vomiting (PONV), regurgitation, aspiration, teeth or lip injury.

Being tested
laryngeal mask airway
Keywords
i-gel, pediatric, laryngeal mask airway, children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • laryngeal mask airwayDevice

    Also called i-gel

    i-gel laryngeal mask airway is a supraglottic airway device made from a medical grade thermoplastic elastomer , is a non-inflatable device to create anatomical seal of the pharyngeal, laryngeal and perilaryngeal structures and avoid compression trauma.

Study groups in NCT03748589
Study groupRoleWhat they receive
airway type 1ExperimentalThe children weighed between 2-5kg are assigned into this group,they are allocated with i-gel laryngeal mask airway type 1
Receives: Device: laryngeal mask airway
airway type 1.5ExperimentalThe children weighed between 5-12kg are assigned into this group,they are allocated with i-gel laryngeal mask airway type 1.5
Receives: Device: laryngeal mask airway
airway type 2ExperimentalThe children weighed between 10-25kg are assigned into this group,they are allocated with i-gel laryngeal mask airway type 2
Receives: Device: laryngeal mask airway
airway type 2.5ExperimentalThe children weighed between 25-35kg are assigned into this group,they are allocated with i-gel laryngeal mask airway type 2.5
Receives: Device: laryngeal mask airway

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Oropharyngeal leak pressure

    reading the airway pressure on the monitor in the anesthesia machine

    Measured: At 5 min after the insertion of i-gel protector

Secondary outcomes (5)
  1. insertion time

    insertion time is measured from the moment of picking up the device to confirming the first the appearance of the ETCO2 on monitor screen

    Measured: During the insertion of i-gel protector

  2. ease of insertion

    Ease of insertion we are using a subjective grading score of 1-4 (1: requiring no additional maneuver, 2:requiring 1 additional maneuver, 3:requiring 2 additional maneuver, 4: requiring more than 3 maneuver)

    Measured: during the insertion of i-gel protector

  3. fiberoptic view

    After insertion of the device, observe the accuracy of insertion location by the fiberoptic views through the device(grade 1: vocal cords not visible, grade 2: vocal cords and anterior epiglottis visible, grade 3: vocal cords and posterior epiglottis visible, grade 4: only vocal cords visible)

    Measured: At 15 min after the insertion of i-gel protector

  4. the rate of successful insertion at first attempt

    the insertion is successful at first attempt

    Measured: During the first attempt insertion of i-gel protector

  5. the ease of gastric tube insertion

    subjective grading scale(1:easy,2:difficult,3:failed insertion) is used for assessing the ease of gastric tube insertion.Easy is defined as placing the tube successfully in the first attempt,difficult is defined as placing the tube successfully within two attempts, failure is defined as inability to establish correct placement within three placements.

    Measured: At 25 min after the insertion of i-gel protector

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2018
  2. Study start12 Dec 2018
  3. Primary completion30 Sep 2019
  4. Study completion30 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
413 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03748589
Sponsor's protocol ID
2018008
Status last verified
Dec 2018
First submitted
24 Oct 2018
Last updated
31 Aug 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Banerjee G, Jain D, Bala I, Gandhi K, Samujh R. Comparison of the ProSeal laryngeal mask airway with the I-Gel in the different head-and-neck positions in anaesthetised paralysed children: A randomised controlled trial. Indian J Anaesth. 2018 Feb;62(2):103-108. doi: 10.4103/ija.IJA_594_17.

    PubMed 29491514
  • Lee YC, Yoon KS, Park SY, Choi SR, Chung CJ. A comparison of i-gel and Laryngeal Mask Airway Supreme during general anesthesia in infants. Korean J Anesthesiol. 2018 Feb;71(1):37-42. doi: 10.4097/kjae.2018.71.1.37. Epub 2017 Aug 14.

    PubMed 29441173
  • Alzahem AM, Aqil M, Alzahrani TA, Aljazaeri AH. Erratum: Ambu AuraOnce versus i-gel laryngeal mask airway in infants and children undergoing surgical procedures. A randomized controlled trial. Saudi Med J. 2017 Dec;38(12):1267. No abstract available.

    PubMed 29209682
  • Yang GZ, Xue FS, Li HX, Liu YY. Comparing i-gel and Ambu AuraOnce laryngeal mask airway in pediatric patients. Saudi Med J. 2017 Dec;38(12):1262-1263. doi: 10.15537/smj.2017.12.20856.

    PubMed 29209679
  • Bhattacharjee S, Som A, Maitra S. Comparison of LMA Supreme with i-gel and LMA ProSeal in children for airway management during general anaesthesia: A meta-analysis of randomized controlled trials. J Clin Anesth. 2017 Sep;41:5-10. doi: 10.1016/j.jclinane.2017.04.019. Epub 2017 Jun 1.

    PubMed 28802606
  • Park JH, Kim JY, Park K, Kil HK. A randomized comparison of volume- and pressure-controlled ventilation in children with the i-gel: Effects on peak inspiratory pressure, oropharyngeal leak pressure, and gastric insufflation. Medicine (Baltimore). 2017 May;96(18):e6772. doi: 10.1097/MD.0000000000006772.

    PubMed 28471973
  • Alzahem AM, Aqil M, Alzahrani TA, Aljazaeri AH. Ambu AuraOnce versus i-gel laryngeal mask airway in infants and children undergoing surgical procedures. A randomized controlled trial. Saudi Med J. 2017 May;38(5):482-490. doi: 10.15537/smj.2017.5.17960.

    PubMed 28439597
  • Jain D, Ghai B, Gandhi K, Banerjee G, Bala I, Samujh R. Evaluation of I-Gel size 2 airway in different degrees of neck flexion in anesthetized children - a prospective, self-controlled trial. Paediatr Anaesth. 2016 Dec;26(12):1136-1141. doi: 10.1111/pan.13001. Epub 2016 Oct 25.

    PubMed 27779349
  • Nirupa R, Gombar S, Ahuja V, Sharma P. A randomised trial to compare i-gel and ProSeal laryngeal mask airway for airway management in paediatric patients. Indian J Anaesth. 2016 Oct;60(10):726-731. doi: 10.4103/0019-5049.191670.

    PubMed 27761035
  • Gu Z, Jin Q, Liu J, Chen L. Observation of ventilation effects of I-gel, Supreme and Ambu AuraOnce with respiratory dynamics monitoring in small children. J Clin Monit Comput. 2017 Oct;31(5):1035-1041. doi: 10.1007/s10877-016-9917-6. Epub 2016 Aug 4.

    PubMed 27492428
  • El-Boghdadly K, Bailey CR, Wiles MD. Postoperative sore throat: a systematic review. Anaesthesia. 2016 Jun;71(6):706-17. doi: 10.1111/anae.13438. Epub 2016 Mar 28.

    PubMed 27158989

Questions about this trial

What is this clinical trial studying?

A study testing laryngeal mask airway in people with the Efficacy and Performance of the Pediatric I-gel Mask, run by Xian Children's Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Oropharyngeal leak pressure (time frame: At 5 min after the insertion of i-gel protector). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03748589, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in